You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selected cancer patients

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting
  • NSCLC
  • +6 more
  • Oral MRT-2359
  • Scottsdale, Arizona
  • +7 more
Dec 20, 2022

Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)

Recruiting
  • Advanced Solid Tumor
  • YL201 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 21, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Jun 1, 2023

Breast Cancer, Early-stage Breast Cancer Trial in Miami (Stereotactic Ablative Breast Radiotherapy)

Recruiting
  • Breast Cancer
  • Early-stage Breast Cancer
  • Stereotactic Ablative Breast Radiotherapy
  • Miami, Florida
    University of Miami
Jan 18, 2023

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

Not yet recruiting
  • Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Oct 30, 2023

Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

Recruiting
  • Advanced Breast Cancer
  • The combination of Dalpiciclib with physician-selected endocrine therapy
  • Chemotherapy selected by the physician
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Selected Subjects With Advanced Solid Tumors Trial in Guangzhou (SKB264)

Not yet recruiting
  • Selected Subjects With Advanced Solid Tumors
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 18, 2022

Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)

Active, not recruiting
  • Metastatic Breast Cancer
  • PARP inhibitor 2X-121
  • Herlev, Denmark
  • +1 more
Feb 1, 2023

Among Healthcare Professionals Treating Metastatic Breast Cancer

Recruiting
  • Breast Cancer
  • Piqray Prescriber's/HCP guide for hyperglycemia
  • Basel, Switzerland
    Novartis Investigative Site
Oct 11, 2022

Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +10 more
  • Los Angeles, California
  • +4 more
Sep 5, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Advanced Tumors Trial in Glasgow, Manchester, Sutton (E7386)

Recruiting
  • Advanced Neoplasms
  • Glasgow, Lanarkshire, United Kingdom
  • +2 more
Nov 30, 2022

LANDscape MApping of Epitopes and T Cell Receptors for Selected

Recruiting
  • Solid Tumor
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 21, 2022

    The Possible Range of No.12a Lymph Node Dissection of Locally

    Recruiting
    • Gastric Cancer
    • No.12a Lymph Node Dissection
    • The reasonable range of No.12a lymph node dissection
    • Tianjin, None Selected, China
      Department of Gastric cancer, Tianjin Medical University Cancer
    Sep 5, 2023

    Advanced Solid Tumor Trial in Brisbane (AMT-116)

    Not yet recruiting
    • Advanced Solid Tumor
    • Brisbane, Queensland, Australia
      ICON Cancer Centre
    Feb 2, 2023

    Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • (no location specified)
    Jun 27, 2022

    Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma Trial (TT-4)

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • (no location specified)
    Apr 26, 2022

    Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

    Recruiting
    • Melanoma
    • OH2
    • Salvage chemotherapy or best supportive care
    • Beijing, Beijing, China
    • +2 more
    May 11, 2023